Key Highlights

  • Corteva (NYSE:CTVA) changed hands at USD 9.19 on November 12, 2026, down 24.34%, with about 17.97 million shares traded, one day after the third-quarter report.
  • Third-quarter net sales declined 9% to USD 1.591 billion, short of projections near USD 1.76 billion, while Latin American sales slid 28% to USD 570 million.
  • The company's revised 2026 view now calls for adjusted operating EBITDA between USD 1.1 billion and USD 1.125 billion, with adjusted Earnings of USD 0.76 to USD 0.80 per share.
  • The shares trade near 6.07 times trailing earnings of USD 1.51 per share, with Market Value around USD 6.13 billion and a trailing Dividend Yield of 5.93%.

Brazil Shifts From Growth Driver to Burden

Corteva (NYSE:CTVA) ranked among the heaviest large-cap decliners on the November 12 market movers screen, carrying forward an after-hours slide of roughly 7% to 8% that started on the evening of November 11. The catalyst was its third-quarter report, which centered on one market. Brazil, usually a dependable source of second-half sales as growers ramp up ahead of soybean planting, came in far below what management anticipated. The company cited tight farmer liquidity, expensive financing, just-in-time buying by growers and distributors, and mounting price pressure on older crop protection chemistries now facing generic rivals. Latin American Revenue contracted 28%, reaching USD 570 million; Volume slid 24% because elevated channel stock postponed orders, and prices were 7% lower. North America climbed 7% to USD 574 million on a 19% jump in volume, Europe, the Middle East and Africa rose 12% to USD 239 million, and Asia Pacific gained 3% to USD 208 million.

Profit Squeeze and the Reduced Outlook

Group net sales decreased 9% to USD 1.591 billion, with prices off 7% and volumes off 2%. The adjusted operating EBITDA measure came in 17% lower at USD 222 million, while adjusted per-share earnings were 57% smaller at USD 0.06. On a reported basis the company recorded a loss from continuing operations of USD 54 million, or USD 0.08 per share, versus a USD 60 million profit a year earlier. The updated 2026 forecast now anticipates adjusted operating EBITDA in a range of USD 1.1 billion to USD 1.125 billion, with adjusted earnings between USD 0.76 and USD 0.80 per share; the market reads this as a downgrade. Corteva also outlined a reorganization of its crop protection Manufacturing and external partner network, with pre-tax charges of about USD 130 million to USD 140 million anticipated in 2026 and the effort mostly finished by 2028. The November 12 decline far exceeded the after-hours move, which suggests investors are now weighing the chance that Brazil's troubles extend into 2027, though that is an interpretation rather than a stated cause.

Valuation and Investor Concerns

Across nine months the trend looks more stable. Sales slipped only 1% to USD 5.357 billion, adjusted EBITDA held flat at USD 943 million, and adjusted earnings jumped 49% to USD 0.76 per share, illustrating how concentrated the damage is in Brazil and a single quarter. At USD 9.19 the shares change hands at roughly 6.07 times trailing diluted earnings of USD 1.51, a measure that dropped 26.40% year over year, and they offer a trailing dividend yield of 5.93%. The main questions are whether Brazilian channel inventory works down during the southern hemisphere season, whether pricing on older chemistries holds up against generics, and whether restructuring savings materialize as scheduled. Strength in North American seed provides an offset.

Where Things Stand

Corteva (NYSE:CTVA) lost 24.34%, landing at USD 9.19 on November 12, 2026, as the post-hours slump carried into trading after quarterly net sales declined 9% to USD 1.591 billion and Latin American sales fell 28%. The 2026 outlook now points to adjusted EBITDA of USD 1.1 billion to USD 1.125 billion and adjusted earnings of USD 0.76 to USD 0.80 per share. The stock trades close to six times trailing earnings, yet Brazil's Credit strain and generic pricing keep near-term visibility limited.